{"filing":{"accession_number":"0001437749-26-029184","cik":"0000832489","ticker":"GOVX","company_name":"GeoVax Labs, Inc.","form":"8-K","filing_date":"2026-08-28","report_date":"2026-08-27","primary_document":"govx20260828_8k.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/832489/000143774926029184/govx20260828_8k.htm"},"events":[{"id":30336,"run_id":27803,"accession_number":"0001437749-26-029184","anchor_item_number":"3.01","event_type":"delisting_risk","event_domain":"terminal","is_material":true,"confidence":0.98,"summary":"GeoVax Labs received a Staff Determination Letter from Nasdaq on August 27, 2026, notifying the company of a decision to delist its common stock due to failure to maintain the minimum $1.00 per share bid price for 30 consecutive business days and non-compliance with the $2,500,000 stockholders' equity requirement. Trading suspension is expected September 8, 2026 absent a timely hearing request. This is a direct delisting notice under Item 3.01, representing a material threat to the company's continued public listing and market access.","company_name":"GeoVax Labs, Inc.","ticker":"GOVX","filing_date":"2026-08-28","form":"8-K","submitted_at":null,"items":[{"id":32904,"accession_number":"0001437749-26-029184","item_number":"3.01","item_title":"Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing.","event_type":"delisting_risk","event_domain":"terminal","is_material":true,"confidence":0.98,"reasoning":"GeoVax Labs received a Staff Determination Letter from Nasdaq on August 27, 2026, notifying the company of a decision to delist its common stock due to failure to maintain the minimum $1.00 per share bid price for 30 consecutive business days and non-compliance with the $2,500,000 stockholders' equity requirement. Trading suspension is expected September 8, 2026 absent a timely hearing request. This is a direct delisting notice under Item 3.01, representing a material threat to the company's continued public listing and market access.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-28T20:19:36.824234+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":32904,"accession_number":"0001437749-26-029184","item_number":"3.01","item_title":"Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing.","event_type":"delisting_risk","event_domain":"terminal","is_material":true,"confidence":0.98,"reasoning":"GeoVax Labs received a Staff Determination Letter from Nasdaq on August 27, 2026, notifying the company of a decision to delist its common stock due to failure to maintain the minimum $1.00 per share bid price for 30 consecutive business days and non-compliance with the $2,500,000 stockholders' equity requirement. Trading suspension is expected September 8, 2026 absent a timely hearing request. This is a direct delisting notice under Item 3.01, representing a material threat to the company's continued public listing and market access.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-28T20:19:36.824234+00:00","company_name":"GeoVax Labs, Inc.","ticker":"GOVX","filing_date":"2026-08-28"}]}